Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Revenue (2020 - 2025)

Historic Revenue for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $128.8 million.

  • Cellebrite DI's Revenue rose 1813.13% to $128.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $475.7 million, marking a year-over-year increase of 1856.22%. This contributed to the annual value of $475.7 million for FY2025, which is 1856.22% up from last year.
  • Per Cellebrite DI's latest filing, its Revenue stood at $128.8 million for Q4 2025, which was up 1813.13% from $126.0 million recorded in Q3 2025.
  • Cellebrite DI's Revenue's 5-year high stood at $128.8 million during Q4 2025, with a 5-year trough of $53.3 million in Q1 2021.
  • In the last 5 years, Cellebrite DI's Revenue had a median value of $80.4 million in 2023 and averaged $85.9 million.
  • As far as peak fluctuations go, Cellebrite DI's Revenue surged by 575.48% in 2022, and later soared by 2694.14% in 2024.
  • Cellebrite DI's Revenue (Quarter) stood at $67.9 million in 2021, then increased by 9.0% to $74.0 million in 2022, then increased by 25.66% to $93.0 million in 2023, then rose by 17.24% to $109.0 million in 2024, then increased by 18.13% to $128.8 million in 2025.
  • Its Revenue stands at $128.8 million for Q4 2025, versus $126.0 million for Q3 2025 and $113.3 million for Q2 2025.